Imisep 250mg/250mg Injection
Marketer
Allites life Sciences Pvt Ltd
Salt Composition
Imipenem (250mg) + Cilastatin (250mg)
Overview Imisep 250mg/250mg Injection
Combiflox 250mg/250mg injection combines two antibiotics to combat serious bacterial infections. Administered only by a healthcare provider, this medication targets infectious microorganisms, preventing infection spread. Complete the prescribed dosage; do not miss injections. Even with improvement, finish the entire treatment course. Common side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions like redness, swelling, and pain may occur but usually resolve. Report worsening side effects immediately to your doctor. Seek immediate medical attention for allergic reactions (skin rash, itching, swelling, difficulty breathing). Inform your doctor of all medications you are taking, including those for pre-existing conditions, before using Combiflox. Pregnant or nursing mothers should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur.
Uses of Imisep 250mg/250mg Injection
Life-threatening bacterial infestations
Major Benefits of Imisep 250mg/250mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Imisep 250mg/250mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imisep 250mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Imisep 250mg/250mg Injection works:
Imisep Injection, containing 250mg of each Imipenem and Cilastatin, utilizes a dual-drug approach to combat bacterial infections. Imipenem, the antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to survive. Cilastatin, a dehydropeptidase I inhibitor, counteracts the enzymatic degradation of Imipenem (by dehydropeptidase I), thereby extending its therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imisep 250mg/250mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Imisep 250mg/250mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The likelihood of Imisep 250mg/250mg Injection posing a risk during breastfeeding is low. Available human data indicates minimal danger to the infant.
DrivingUNSAFE
Imisep 250mg/250mg injections may induce adverse reactions impacting driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), can impair some patients' ability to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should use Imisep 250mg/250mg Injection cautiously. Dosage modification for Imisep 250mg/250mg Injection may be necessary; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Imisep 250mg/250mg Injection in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Imisep 250mg/250mg Injection :
Should you forget a scheduled Imisep 250mg/250mg Injection, seek medical advice.
Facts to Know About Imisep 250mg/250mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Antimicrobial agents |
3,018 People bought this recently